Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Neurocrine Biosciences Is Soaring

TheMotleyFool 
0 0 02.11.17
Here's Why Neurocrine Biosciences Is SoaringPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
 
Here's Why Neurocrine Biosciences Is Soaring

In response to the company reporting better-than-expected quarterly results, shares of Neurocrine Biosciences (NASDAQ: NBIX), a commercial stage biotech focused on neurological and endocrine disorders, rose 17% as of 11:45 a.m. EDT Thursday.

Here's a review of the key takeaways from the company's third quarter:

Commenting on the quarter, CEO Kevin Gorman stated:

Continue reading


Source: Fool.com

Neurocrine Bioscience Stock

€132.20
-0.900%
Neurocrine Bioscience shows a slight decrease today, losing -€1.200 (-0.900%) compared to yesterday.
The stock is an absolute favorite of our community with 62 Buy predictions and no Sell predictions.
As a result the target price of 160 € shows a positive potential of 21.03% compared to the current price of 132.2 € for Neurocrine Bioscience.
Show more
Like: 0
NBIX
Share

Comments

Not a member yet? Sign up for free!